Dr. Bieke Lambert, Nucleaire Geneeskunde SRL

Dr. Bieke Lambert, Nucleaire Geneeskunde reported total assets of €1.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).

By total assets for 2025, Dr. Bieke Lambert, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0643.684.674 · VAT BE0643684674
9030 Ghent
active in Medical specialists activities (NACE 86220)
operating since 27 Nov 2015 (≈ 11 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Bieke Lambert, Nucleaire Geneeskunde shows with a free account.

See the score
Profile
SRL since 2015
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result427,661 €
Equity929,368 €
Cash40,538 €
EBITDA576,535 €
Total assets€1.08m
The line marks its sector median: 72.2% (8672 companies).

Change 2022 → 2025: Equity +6 % Total assets +3 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Bieke Lambert, Nucleaire Geneeskunde's annual accounts

20252024202320222021
Net result427,661 €
Equity929,368 €
Cash40,538 €
EBITDA576,535 €
Total assets€1.08m

Filed annual accounts

  • Year ended 30 Sep 2025filed on 31 Mar 2026
  • Year ended 30 Sep 2024filed on 30 Apr 2025
  • Year ended 30 Sep 2023filed on 30 Apr 2024
  • Year ended 30 Sep 2022filed on 30 Apr 2023
  • Year ended 30 Sep 2021filed on 31 Mar 2022

Dr. Bieke Lambert, Nucleaire Geneeskunde's financial analysis

Management and control of Dr. Bieke Lambert, Nucleaire Geneeskunde

1 active director(s) in the register.

Dr. Bieke Lambert, Nucleaire Geneeskunde's shareholders and holdings →

Dr. Bieke Lambert, Nucleaire Geneeskunde's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0643.684.674
VAT number
BE0643684674
Peppol
Registered · 0208:0643684674 · as of 10 Nov 2026
Legal form
SRL
Incorporated
27 Nov 2015
Registered office
9030 Ghent
Latest accounts
2025 · filed on 31 Mar 2026
Activity
Medical specialists activities (NACE 86220)

Dr. Bieke Lambert, Nucleaire Geneeskunde (SRL) has been based in Ghent since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 427,661 € and equity of 929,368 €; its revenue is not published. Its solvency stands at 86.2%, above the median of its sector (72.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Bieke Lambert, Nucleaire Geneeskunde

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Bieke Lambert, Nucleaire Geneeskunde

What is the revenue of Dr. Bieke Lambert, Nucleaire Geneeskunde?

Dr. Bieke Lambert, Nucleaire Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Bieke Lambert, Nucleaire Geneeskunde?

In Belgium, the VAT number is the company number prefixed with BE: BE0643684674 for Dr. Bieke Lambert, Nucleaire Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0643.684.674.

Where is the registered office of Dr. Bieke Lambert, Nucleaire Geneeskunde?

According to the CBE register, the registered office of Dr. Bieke Lambert, Nucleaire Geneeskunde is in 9030 Ghent.

What is the equity of Dr. Bieke Lambert, Nucleaire Geneeskunde?

At the close of the 2025 financial year, the equity of Dr. Bieke Lambert, Nucleaire Geneeskunde amounts to 929,368 €, a solvency of 86.2% of total assets.

Who manages Dr. Bieke Lambert, Nucleaire Geneeskunde?

The register lists 1 active mandates at Dr. Bieke Lambert, Nucleaire Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Dr. Bieke Lambert, Nucleaire Geneeskunde within its sector?

By total assets for 2025, Dr. Bieke Lambert, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.

Idonis

The full file of Dr. Bieke Lambert, Nucleaire Geneeskunde

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 18 Jul 2026

No credit card, no commitment.

What each plan unlocks →